Douglas Campbell Jones - Publications

2004 University of Texas at Austin, Austin, Texas, U.S.A. 

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Jones DC, Lakatos A, Rogge GA, Kuhar MJ. Regulation of cocaine- and amphetamine-regulated transcript mRNA expression by calcium-mediated signaling in GH3 cells. Neuroscience. 160: 339-47. PMID 19258027 DOI: 10.1016/j.neuroscience.2009.02.051  0.56
2009 Rogge GA, Jones DC, Green T, Nestler E, Kuhar MJ. Regulation of CART peptide expression by CREB in the rat nucleus accumbens in vivo. Brain Research. 1251: 42-52. PMID 19046951 DOI: 10.1016/j.brainres.2008.11.011  0.56
2008 Rogge G, Jones D, Hubert GW, Lin Y, Kuhar MJ. CART peptides: regulators of body weight, reward and other functions. Nature Reviews. Neuroscience. 9: 747-58. PMID 18802445 DOI: 10.1038/nrn2493  0.56
2008 Jones DC, Miller GW. The effects of environmental neurotoxicants on the dopaminergic system: A possible role in drug addiction. Biochemical Pharmacology. 76: 569-81. PMID 18555207 DOI: 10.1016/j.bcp.2008.05.010  0.56
2008 Jones DC, Kuhar MJ. CART receptor binding in primary cell cultures of the rat nucleus accumbens. Synapse (New York, N.Y.). 62: 122-7. PMID 18000808 DOI: 10.1002/syn.20476  0.56
2008 Hubert GW, Jones DC, Moffett MC, Rogge G, Kuhar MJ. CART peptides as modulators of dopamine and psychostimulants and interactions with the mesolimbic dopaminergic system. Biochemical Pharmacology. 75: 57-62. PMID 17854774 DOI: 10.1016/j.bcp.2007.07.028  0.56
2007 Vicentic A, Jones DC. The CART (cocaine- and amphetamine-regulated transcript) system in appetite and drug addiction. The Journal of Pharmacology and Experimental Therapeutics. 320: 499-506. PMID 16840648 DOI: 10.1124/jpet.105.091512  0.56
2006 Jaworski JN, Jones DC. The role of CART in the reward/reinforcing properties of psychostimulants. Peptides. 27: 1993-2004. PMID 16766084 DOI: 10.1016/j.peptides.2006.03.034  0.56
2006 Vicentic A, Lakatos A, Jones D. The CART receptors: background and recent advances. Peptides. 27: 1934-7. PMID 16713658 DOI: 10.1016/j.peptides.2006.03.031  0.56
2006 Hunter RG, Jones D, Vicentic A, Hue G, Rye D, Kuhar MJ. Regulation of CART mRNA in the rat nucleus accumbens via D3 dopamine receptors. Neuropharmacology. 50: 858-64. PMID 16458333 DOI: 10.1016/j.neuropharm.2005.12.007  0.56
2006 Jones DC, Kuhar MJ. Cocaine-amphetamine-regulated transcript expression in the rat nucleus accumbens is regulated by adenylyl cyclase and the cyclic adenosine 5'-monophosphate/protein kinase a second messenger system. The Journal of Pharmacology and Experimental Therapeutics. 317: 454-61. PMID 16322355 DOI: 10.1124/jpet.105.096123  0.56
2005 Sprague JE, Nichols DE. Neurotoxicity of MDMA (ecstasy): beyond metabolism. Trends in Pharmacological Sciences. 26: 59-60; author reply . PMID 15681020 DOI: 10.1016/  0.56
2005 Jones DC, Duvauchelle C, Ikegami A, Olsen CM, Lau SS, de la Torre R, Monks TJ. Serotonergic neurotoxic metabolites of ecstasy identified in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 313: 422-31. PMID 15634943 DOI: 10.1124/jpet.104.077628  0.56
2004 Monks TJ, Jones DC, Bai F, Lau SS. The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity. Therapeutic Drug Monitoring. 26: 132-6. PMID 15228153 DOI: 10.1097/00007691-200404000-00008  0.56
2004 Jones DC, Lau SS, Monks TJ. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells. The Journal of Pharmacology and Experimental Therapeutics. 311: 298-306. PMID 15169827 DOI: 10.1124/jpet.104.069260  0.56
2003 Jones DC, Prabhakaran K, Li L, Gunasekar PG, Shou Y, Borowitz JL, Isom GE. Cyanide enhancement of dopamine-induced apoptosis in mesencephalic cells involves mitochondrial dysfunction and oxidative stress. Neurotoxicology. 24: 333-42. PMID 12782099 DOI: 10.1016/S0161-813X(03)00042-1  0.56
2002 Monks TJ, Jones DC. The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers. Current Drug Metabolism. 3: 425-38. PMID 12093358 DOI: 10.2174/1389200023337388  0.56
2001 Bai F, Jones DC, Lau SS, Monks TJ. Serotonergic neurotoxicity of 3,4-(±)-methylenedioxyamphetamine and 3,4-(±)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of γ-glutamyl transpeptidase Chemical Research in Toxicology. 14: 863-870. PMID 11453733 DOI: 10.1021/tx010011l  0.56
2000 Jones DC, Gunasekar PG, Borowitz JL, Isom GE. Dopamine-induced apoptosis is mediated by oxidative stress and is enhanced by cyanide in differentiated PC12 cells Journal of Neurochemistry. 74: 2296-2304. PMID 10820189 DOI: 10.1046/j.1471-4159.2000.0742296.x  0.56
1995 Baker RE, Ballantyne D, Bingmann D, Jones D, Widman G. Rhythm generation in organotypic medullary cultures of newborn rats International Journal of Developmental Neuroscience. 13: 799-809. PMID 8770653 DOI: 10.1016/0736-5748(95)00081-X  0.56
1995 Bingmann D, Baker RE, Ballantyne D, Jones D, Widman G. Suppression of rhythmic discharges of medullary neurones in organotypic cultures of new-born rats by calcium antagonists Neuroscience Letters. 199: 187-190. PMID 8577394 DOI: 10.1016/0304-3940(95)12047-8  0.56
Show low-probability matches.